Global Patterns and Trends in Total Burden of Hepatitis B from 1990 to 2019 and Predictions to 2030

References

• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555. doi:10.1016/s0140-6736(15)61412-x
   PubMed Web of Science ®Google Scholar
• Sepanlou SG, Safiri S, Bisignano C. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245–266. doi:10.1016/s2468-1253(19)30349-8
   PubMed Web of Science ®Google Scholar
• Yang J, Pan G, Guan L, et al. The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels. Cancer Med. 2022;11(5):1357–1370. doi:10.1002/cam4.4530
   Web of Science ®Google Scholar
• World Health Organization. Hepatitis B. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b. Accessed June 21, 2022.
   Google Scholar
• World Health Organization. Global hepatitis report; 2017. Available from: https://www.who.int/publications/i/item/9789241565455. Accessed June 21, 2022.
   Google Scholar
• Wang G, Duan Z. Guidelines for prevention and treatment of chronic hepatitis B. J Clin Transl Hepatol. 2021;9(5):769–791. doi:10.14218/jcth.2021.00209
   PubMed Web of Science ®Google Scholar
• Wang X, Liu J, Wang Q, et al. Economic-related inequalities in hepatitis B virus infection among 115.8 million pregnant women in China from 2013 to 2020. EClinicalMedicine. 2022;49:101465. doi:10.1016/j.eclinm.2022.101465
   Google Scholar
• Ríos-Hincapié CY, Murad-Rivera R, Tohme RA, et al. Progress towards the elimination of hepatitis B in children in Colombia: a novel two-phase study approach. J Viral Hepat. 2022. doi:10.1111/jvh.13719
   Web of Science ®Google Scholar
• Lampertico P, Agarwal K, Berg T. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–398. doi:10.1016/j.jhep.2017.03.021
   PubMed Web of Science ®Google Scholar
• Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599. doi:10.1002/hep.29800
   PubMed Web of Science ®Google Scholar
• Cui F, Shen L, Li L, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–772. doi:10.3201/eid2305.161477
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550–6557. doi:10.1016/j.vaccine.2009.08.048
   PubMed Web of Science ®Google Scholar
• Li C, He WQ. The impact of universal hepatitis B vaccine on the trend of liver cancer from the global burden of disease study 2017. Liver Int. 2021;41(8):1762–1774. doi:10.1111/liv.14821
   Web of Science ®Google Scholar
• World Health Organization. Blood safety and availability. Available from: https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability. Accessed June 22, 2022.
   Google Scholar
• Liu J, Liu M. Progress and challenges in achieving the WHO goal on elimination of hepatitis b by 2030 in China (in Chinese). Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(6):605–609. doi:10.3760/cma.j.issn.0254-6450.2019.06.001
   Google Scholar
• Su S, Wong WC, Zou Z, et al. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. Lancet Global Health. 2022;10(2):e278–e287. doi:10.1016/s2214-109x(21)00517-9
   PubMed Web of Science ®Google Scholar
• Behzadi P, Behzadi E, Alavian SM. DNA microarray technology in HBV genotyping. Minerva Med. 2017;108(5):473–476. doi:10.23736/s0026-4806.17.05059-5
   Web of Science ®Google Scholar
• Behzadi P, Ranjbar R, Alavian SM. Nucleic acid-based approaches for detection of viral hepatitis. Jundishapur J Microbiol. 2015;8(1):e17449. doi:10.5812/jjm.17449
   PubMed Web of Science ®Google Scholar
• Global burden of disease study 2019 (GBD 2019) data resources. Available from: https://ghdx.healthdata.org/gbd-2019. Accessed May 31, 2022.
   Google Scholar
• A new way to measure progress in global health. Available from: https://www.humanosphere.org/global-health/2016/10/a-new-way-to-measure-progress-global-health/. Accessed May 31, 2022.
   Google Scholar
• Lacey BW. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1160–1203. doi:10.1016/s0140-6736(20)30977-6
   Web of Science ®Google Scholar
• Locally weighted scatterplot smoothing (LOWESS). Available from: https://en.wikipedia.org/wiki/Local_regression. Accessed November 16, 2022.
   Google Scholar
• Autoregressive integrated moving average (ARIMA). Available from: https://en.wikipedia.org/wiki/Autoregressive_integrated_moving_average. Accessed November 16, 2022.
   Google Scholar
• Guo K, Song S, Qiu L, Wang X, Ma S. Prediction of red blood cell demand for pediatric patients using a time-series model: a single-center study in China. Front Med. 2022;9:706284. doi:10.3389/fmed.2022.706284
   Web of Science ®Google Scholar
• Society of Infectious Diseases and Chinese Medical Association GCC. Guidelines for prevention and control of mother to child transmission of hepatitis B virus in China-2019 Edition (in Chinese). Chin J Infect Dis. 2019;37(7):388–396. doi:10.3760/cma.j.issn.1000-6680.2019.07.002
   Google Scholar
• Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis. 2012;16(2):e82–e88. doi:10.1016/j.ijid.2011.10.009
   PubMed Web of Science ®Google Scholar
• Liao X, Liang Z. Strategy vaccination against hepatitis B in China. Hum Vaccin Immunother. 2015;11(6):1534–1539. doi:10.4161/21645515.2014.980206
   PubMed Web of Science ®Google Scholar
• Jia Y, Li L, Cui F, et al. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China. Hum Vaccin Immunother. 2014;10(10):2983–2991. doi:10.4161/hv.29944
   PubMed Web of Science ®Google Scholar
• Rauniyar SK, Munkhbat E, Ueda P, Yoneoka D, Shibuya K, Nomura S. Timeliness of routine vaccination among children and determinants associated with age-appropriate vaccination in Mongolia. Heliyon. 2020;6(9):e04898. doi:10.1016/j.heliyon.2020.e04898
   Web of Science ®Google Scholar
• The proportion of elderly people (65 years and older) in the total population of all countries in the world. Available from: https://www.kylc.com/stats/global/yearly_overview/g_population_65above_perc.html. Accessed June 25, 2022.
   Google Scholar
• Kumar GS, Pezzi C, Payton C, et al. Health of asylees compared to refugees in the United States using domestic medical examination data, 2014–2016: a cross-sectional analysis. Clin Infect Dis. 2021;73(8):1492–1499. doi:10.1093/cid/ciab502
   Web of Science ®Google Scholar
• Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–683. doi:10.1016/j.jhep.2018.12.001
   PubMed Web of Science ®Google Scholar
• Kuehn BM. Age range is expanded for universal hepatitis B vaccination. JAMA. 2022;327(18):1749. doi:10.1001/jama.2022.6515
   Web of Science ®Google Scholar
• Weng MK, Doshani M, Khan MA, et al. Universal hepatitis B vaccination in adults aged 19–59 years: updated recommendations of the advisory committee on immunization practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(13):477–483. doi:10.15585/mmwr.mm7113a1
   Web of Science ®Google Scholar
• Sheena BS, Hiebert L, Han H, et al. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796–829. doi:10.1016/s2468-1253(22)00124-8
   Google Scholar